Centaurus Financial’s Colgate-Palmolive CL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $238K | Sell |
2,596
-34
| -1% | -$2.98K | 0.01% | 827 |
|
|
2026
Q1 | $224K | Sell |
2,630
-96
| -4% | -$8.56K | 0.01% | 782 |
|
|
2025
Q4 | $215K | Buy |
2,726
+269
| +11% | +$21.1K | 0.01% | 779 |
|
|
2025
Q3 | $196K | Sell |
2,457
-500
| -17% | -$42.7K | 0.01% | 796 |
|
|
2025
Q2 | $269K | Hold |
2,957
| – | – | 0.02% | 643 |
|
|
2025
Q1 | $277K | Buy |
2,957
+30
| +1% | +$2.69K | 0.02% | 597 |
|
|
2024
Q4 | $266K | Sell |
2,927
-494
| -14% | -$47.1K | 0.02% | 588 |
|
|
2024
Q3 | $355K | Buy |
3,421
+464
| +16% | +$47.3K | 0.02% | 487 |
|
|
2024
Q2 | $287K | Hold |
2,957
| – | – | 0.02% | 511 |
|
|
2024
Q1 | $266K | Sell |
2,957
-489
| -14% | -$41.4K | 0.02% | 536 |
|
|
2023
Q4 | $275K | Sell |
3,446
-527
| -13% | -$39.6K | 0.02% | 507 |
|
|
2023
Q3 | $283K | Buy |
3,973
+699
| +21% | +$52.3K | 0.02% | 478 |
|
|
2023
Q2 | $252K | Sell |
3,274
-658
| -17% | -$50.9K | 0.02% | 505 |
|
|
2023
Q1 | $295K | Buy |
3,932
+475
| +14% | +$35.3K | 0.02% | 542 |
|
|
2022
Q4 | $272K | Sell |
3,457
-793
| -19% | -$59.5K | 0.03% | 518 |
|
|
2022
Q3 | $299K | Sell |
4,250
-17
| -0.4% | -$1.33K | 0.03% | 489 |
|
|
2022
Q2 | $342K | Buy |
4,267
+20
| +0.5% | +$1.56K | 0.03% | 464 |
|
|
2022
Q1 | $322K | Buy |
4,247
+48
| +1% | +$3.8K | 0.03% | 529 |
|
|
2021
Q4 | $358K | Buy |
4,199
+357
| +9% | +$27.9K | 0.03% | 531 |
|
|
2021
Q3 | $290K | Hold |
3,842
| – | – | 0.02% | 558 |
|
|
2021
Q2 | $313K | Buy |
3,842
+322
| +9% | +$26.3K | 0.03% | 558 |
|
|
2021
Q1 | $277K | Buy |
3,520
+465
| +15% | +$36.4K | 0.03% | 516 |
|
|
2020
Q4 | $261K | Buy |
3,055
+400
| +15% | +$33.1K | 0.03% | 493 |
|
|
2020
Q3 | $205K | Buy |
2,655
+152
| +6% | +$11.6K | 0.03% | 446 |
|
|
2020
Q2 | $183K | Hold |
2,503
| – | – | 0.03% | 446 |
|
|
2020
Q1 | $166K | Buy |
2,503
+90
| +4% | +$6.35K | 0.03% | 381 |
|
|
2019
Q4 | $166K | Sell |
2,413
-583
| -19% | -$39.7K | 0.02% | 496 |
|
|
2019
Q3 | $220K | Sell |
2,996
-612
| -17% | -$44.4K | 0.03% | 398 |
|
|
2019
Q2 | $259K | Buy |
3,608
+17
| +0.5% | +$1.21K | 0.04% | 382 |
|
|
2019
Q1 | $246K | Sell |
3,591
-409
| -10% | -$26.4K | 0.04% | 367 |
|
|
2018
Q4 | $211K | Buy |
4,000
+1,000
| +33% | +$62.6K | 0.05% | 316 |
|
|
2018
Q3 | $232K | Sell |
3,000
-5,262
| -64% | -$350K | 0.04% | 355 |
|
|
2018
Q2 | $535K | Buy |
8,262
+4,924
| +148% | +$322K | 0.07% | 288 |
|
|
2018
Q1 | $239K | Sell |
3,338
-83
| -2% | -$5.97K | 0.06% | 298 |
|
|
2017
Q4 | $258K | Buy |
+3,421
| New | +$250K | 0.07% | 264 |
|
Other funds holding CL
Centaurus Financial's CL Position: Q2 2026 in Review
Centaurus Financial reduced its Colgate-Palmolive (CL) stake by 1.3% in Q2 2026, selling an estimated $2.98K and leaving 2,596 shares worth $238K. The position accounts for 0.01% of the portfolio, ranked #827.
Centaurus Financial first reported a position in CL in Q4 2017 and has held it in 35 quarters since. The position peaked at $535K in Q2 2018. 2,023 funds tracked by Wall St. Rank hold CL as of Q2 2026.
- Centaurus Financial held 2,596 shares of Colgate-Palmolive worth $238K as of Q2 2026.
- Centaurus Financial sold 34 Colgate-Palmolive shares in Q2 2026, an estimated $2.98K.
- Colgate-Palmolive made up 0.01% of Centaurus Financial's portfolio in Q2 2026, its #827 holding.
- Centaurus Financial first reported a position in Colgate-Palmolive in Q4 2017 and has held it in 35 quarters since.
- Centaurus Financial's Colgate-Palmolive position peaked at $535K in Q2 2018.
- 2,023 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.
Based on Centaurus Financial's 13F filing for Q2 2026, filed 17 Aug 2026.